EdgarLookup

Milestone Pharmaceuticals Inc. — SC 13G/A Filings

25 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by Milestone Pharmaceuticals Inc. (MIST), sorted by most recent first. Each row links to the full filing on EdgarLookup. Milestone Pharmaceuticals Inc. has filed 25 SC 13G/A documents with the SEC since 2007. To view all SEC filings by Milestone Pharmaceuticals Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 144 3 4 4/A 424B4 424B5 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT PRE 14A REGDEX S-1 S-1/A S-1MEF S-3 S-3/A S-3MEF S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
SC 13G/A 0001319244-24-000053 Oct 29, 2024
SC 13G/A SC 13G/A 0001104659-24-024237 Feb 14, 2024
SC 13G/A MILESTONE PHARMACEUTICALS INC. 0000902664-24-001547 Feb 14, 2024
SC 13G/A 0001319244-24-000017 Jan 29, 2024
SC 13G/A 0001086364-24-002358 Jan 24, 2024
SC 13G/A AMENDMENT NO. 1 0000947871-23-000181 Feb 14, 2023
SC 13G/A SC 13G/A 0001104659-23-021796 Feb 14, 2023
SC 13G/A SC 13G/A 0001104659-23-021606 Feb 14, 2023
SC 13G/A 0000895345-23-000140 Feb 14, 2023
SC 13G/A SC 13G/A 0001193125-23-037890 Feb 14, 2023
SC 13G/A 0001306550-23-008628 Feb 13, 2023
SC 13G/A 0001319244-23-000006 Jan 18, 2023
SC 13G/A SC 13G/A 0001193125-22-042043 Feb 14, 2022
SC 13G/A SC 13G/A 0001193125-22-041930 Feb 14, 2022
SC 13G/A SC 13G/A 0001104659-22-022781 Feb 14, 2022
SC 13G/A 0000902664-22-001576 Feb 14, 2022
SC 13G/A AMENDMENT NO. 1 0000947871-22-000206 Feb 11, 2022
SC 13G/A SC 13G/A 0001193125-21-045120 Feb 16, 2021
SC 13G/A 0000080255-21-001322 Feb 16, 2021
SC 13G/A SC 13G/A 0001193125-21-043131 Feb 16, 2021
SC 13G/A 0001493152-21-003495 Feb 12, 2021
SC 13G/A AMENDMENT NO. 1 0000950142-21-000502 Feb 12, 2021
SC 13G/A SCHEDULE 13G/A FOR MILESTONE PHARMACEUTICALS INC. ON BEHALF OF DOMAIN PARTNERS V 0000904454-21-000039 Jan 21, 2021
SC 13G/A SCHEDULE 13G/A 0001104659-20-043073 Apr 3, 2020
SC 13G/A 0001493152-20-002407 Feb 14, 2020